---
title: "Genenta Science tumbles 19%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304482260.md"
description: "Genenta Science fell 18.91% to US$0.5676. Down 59.73% from IPO price."
datetime: "2026-11-05T15:00:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304482260.md)
  - [en](https://longbridge.com/en/news/304482260.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304482260.md)
generator: "portal-rs"
---

# Genenta Science tumbles 19%

Genenta Science (SAEN.US) tumbled nearly **19%** during regular trading to **$0.5676**.

The stock is down 59.73% from its IPO price and sits 78.00% below its 52-week high of US$2.580. The intraday swing reached 12.31%.

The Nasdaq Composite is down 4.56% over the past five sessions and up 7.52% year to date.

The company received a deficiency notice from Nasdaq for failing to meet the minimum bid price requirement after its American Depositary Shares closed below the $1.00 threshold for 30 consecutive trading days.

Genenta has an initial 180-day compliance period ending April 14, 2027, to regain compliance. Shareholders have authorized a reverse stock split at a ratio between 1-for-10 and 1-for-20, which management may implement to address the deficiency. Trading will continue with no immediate delisting.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [SAEN.US](https://longbridge.com/en/quote/SAEN.US.md)

## Related News & Research

- [INSTANT VIEW-Nvidia earnings beat estimates; attention turns to call](https://longbridge.com/en/news/305875718.md)
- [Marvell outlines custom HBM design approach at 2026 OCP Global Summit](https://longbridge.com/en/news/305857411.md)
- [Will Upper Stage Recovery Change SpaceX's (SPCX) Narrative](https://longbridge.com/en/news/305914563.md)
- [Sandisk (SNDK) Stock Could Be 42% Below Fair Value Following Data Center Regulation Fears](https://longbridge.com/en/news/305917622.md)
- [AI’s 48-Hour Stress Test Starts Now](https://longbridge.com/en/news/305878236.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**